Allison Whitten AstraZeneca reports mixed Phase 3 results across oncology and rare disease AstraZeneca reported mixed late-stage clinical results, with its Claudin 18.2-targeting antibody-drug conjugate sonesitatug vedotin meeting its primary endpoint in patients with previously treated advanced gastric cancer, while rare disease therapy Ultomiris missed the primary endpoint in a Phase 3 trial for thrombotic microangiopathy following haematopoietic stem cell transplantation (HSCT-TMA)
This study suggested that Epithalon may possess anti-mutagenic potential
What 10 Years of Using Peptides Has Taught Me Ive been the Chief Medical Officer of the Boulder Longevity Institute for 20 years
About the Company GST Registration Year 2023 Legal Status of Firm Limited Company Nature of Business Trader - Wholesaler/Distributor Number of Employees Upto 10 People Annual Turnover 40 L - 1.5 Cr IndiaMART Member Since Sept 2019 GST 27**********1ZL Import Export Code (IEC) *******73M Exports to United States Of America | United Kingdom | Canada | Ireland | Australia 2022 , We Prakshay Impex Private Limited are Wholesaler & Exporter of an Pharmaceutical Tablets, Anti Cancer Medicines, Skin Care Products, Anti HIV Drugs, Pharmaceutical Drugs, Pharmaceutical Injections, Pharmaceutical Medicines, Eye Drops etc
p = 0.55, Supplementary Fig
Resistance training helps preserve the muscle that keeps metabolism healthy, and steady protein intake supports that muscle, so the peptide becomes one part of a sustainable approach